newsfilter
← Latest News
GlobeNewswire·

Viracta Therapeutics to Present at Upcoming Investor Conferences

SAN DIEGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (NASDAQ:VIRX), a precision oncology company targeting virus-associated cancers, today announced that company leadership is scheduled to present